James Karrels, Vice President, Chief Financial Officer [-] Mr. Karrels has 20 years of experience in finance, including approximately 15 years working for, or on behalf of, life science companies.
Prior to joining MacroGenics in May 2008, he was at Jazz Pharmaceuticals, Inc., most recently serving as Executive Director of Finance, where he was responsible for the company's financial planning and analysis and investor relations activities.
While at Jazz, he
worked very closely with the senior executives to take the company public in 2007.
Mr. Karrels began his career as a financial analyst at Merrill Lynch & Co. in 1989 and advanced to the position of Director in the Investment Banking Group, focusing exclusively on healthcare clients.
tenure at Merrill Lynch
participated in more than 30 sole or lead-managed transactions, representing over $25 billion in aggregate transaction value.
activities included the marketing, structuring and execution of IPOs, equity and convertible debt financings, mergers and acquisitions, spin-offs and other transactions.
He serves as Co-Chair of the Steering Committee, Baltimore-Washington Chapter of the Association of Bioscience Financial Officers.
Mr. Karrels holds an M.B.A. from Stanford University and a B.B.A. from the University of Notre Dame.